A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours

BACKGROUND: On the basis of preclinical studies of NC-6004, a cisplatin-incorporated micellar formulation, we hypothesised that NC-6004 could show lower toxicity than cisplatin and show greater anti-tumour activity in phase I study. METHODS: A total of 17 patients were recruited in a range of advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Plummer, R, Wilson, R H, Calvert, H, Boddy, A V, Griffin, M, Sludden, J, Tilby, M J, Eatock, M, Pearson, D G, Ottley, C J, Matsumura, Y, Kataoka, K, Nishiya, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049602/
https://www.ncbi.nlm.nih.gov/pubmed/21285987
http://dx.doi.org/10.1038/bjc.2011.6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049602/
https://www.ncbi.nlm.nih.gov/pubmed/21285987
http://dx.doi.org/10.1038/bjc.2011.6

Ejemplares similares